Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Braz. j. med. biol. res ; 44(11): 1134-1140, Nov. 2011. ilus, tab
Article in English | LILACS | ID: lil-604281

ABSTRACT

Human T lymphotropic virus type 1 (HTLV-1) is the causal agent of myelopathy/tropical spastic paraparesis (HAM/TSP), a disease mediated by the immune response. HTLV-1 induces a spontaneous proliferation and production of pro-inflammatory cytokines by T cells, and increasing interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) levels are potentially involved in tissue damage in diseases related to HTLV-1. This exaggerated immune response is also due to an inability of the natural regulatory mechanisms to down-modulate the immune response in this group of patients. TNF-α inhibitors reduce inflammation and have been shown to improve chronic inflammatory diseases in clinical trials. The aim of this study was to evaluate the ability of pentoxifylline, forskolin, rolipram, and thalidomide to decrease in vitro production of TNF-α and IFN-γ in cells of HTLV-1-infected subjects. Participants of the study included 19 patients with HAM/TSP (mean age, 53 ± 11; male:female ratio, 1:1) and 18 HTLV-1 carriers (mean age, 47 ± 11; male:female ratio, 1:2.6). Cytokines were determined by ELISA in supernatants of mononuclear cell cultures. Pentoxifylline inhibited TNF-α and IFN-γ synthesis with the minimum dose used (50 µM). The results with forskolin were similar to those observed with pentoxifylline. The doses of rolipram used were 0.01-1 µM and the best inhibition of TNF-α production was achieved with 1 µM and for IFN-γ production it was 0.01 µM. The minimum dose of thalidomide used (1 µM) inhibited TNF-α production but thalidomide did not inhibit IFN-γ production even when the maximum dose (50 µM) was used. All drugs had an in vitro inhibitory effect on TNF-α production and, with the exception of thalidomide, all of them also decreased IFN-γ production.


Subject(s)
Female , Humans , Male , Middle Aged , Anti-Inflammatory Agents/pharmacology , HTLV-I Infections/metabolism , Immunosuppressive Agents/pharmacology , Interferon-gamma/biosynthesis , Leukocytes, Mononuclear/drug effects , Tumor Necrosis Factor-alpha/biosynthesis , Case-Control Studies , Colforsin/pharmacology , HTLV-I Infections/immunology , Leukocytes, Mononuclear/metabolism , Pentoxifylline/pharmacology , Rolipram/pharmacology , Statistics, Nonparametric , Thalidomide/pharmacology
2.
Acta méd. colomb ; 15(5): 328-32, sept.-oct. 1990. ilus, tab
Article in Spanish | LILACS | ID: lil-183163

ABSTRACT

La infección por el virus linfotrópico humano tipo I (HTLV-I) se ha asociado a la paraparesia espástica tropical (PET) y a la leucemia/linfoma de células T del adulto (ATL). Recientemete se demostró que los desordenes del metabolismo del calcio que acompañan la ATL son debidos a la secreción de un factor con actividad de parthormonas producido por los linfocitos infectados por el HTVL-I. Se presenta el caso de una paciente con anticuerpos contra el HTVL-I, anormalidades en el metabolismo del calcio y con parámetros que la clasifican en uno de los subtipos de ATL.


Subject(s)
Humans , Female , Middle Aged , HTLV-I Infections/complications , Paraparesis, Tropical Spastic/complications , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/complications , HTLV-I Infections/immunology , HTLV-I Infections/metabolism , Paraparesis, Tropical Spastic/immunology , Paraparesis, Tropical Spastic/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL